Uncategorized

Second patient death reported with gene therapy for muscular dystrophy – AP News

Posted on Author Tim Hodges Comments Off on Second patient death reported with gene therapy for muscular dystrophy – AP News
  1. Second patient death reported with gene therapy for muscular dystrophy  AP News
  2. Sarepta Provides Safety Update for ELEVIDYS and Initiates Steps to Strengthen Safety in Non-Ambulatory Individuals with Duchenne  Sarepta Therapeutics
  3. Biotech pauses trial after second patient death linked to gene therapy  The Washington Post
  4. Roche Pauses Commercial and Clinical Use of Elevidys After Fatal Liver Failures  WSJ
  5. After second Sarepta death, Duchenne muscular dystrophy community is racked by recrimination and worry  statnews.com